ResearcherWashington University in St. LouisActive in the last 2 years
Blake E. Sells
Matched on ORCID iD 0000-0002-4500-1256; OpenAlex author ID A5063941522; NIH RePORTER profile ID 78095338. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 1
- Labs led
- 0
- Collaborators
- 19
2024: 1 paper · 2025: 1 paper · 2026: 1 paper, 1 grant
Papers 3
- Multi-modal spatial glycomic analysis of lymphoid aggregates in prostate and pancreatic cancer tissues. Co-author DOI 10.3389/fonc.2026.1935795↗
- Combined Flt3L and CD40 agonism restores dendritic cell-driven T cell immunity in pancreatic cancer. Co-author DOI 10.1126/sciimmunol.adp3978↗
- Senescence Defines a Distinct Subset of Myofibroblasts That Orchestrates Immunosuppression in Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-23-0428↗
Grants 1
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Liang‐I Kang · 3 shared papers, 2024–2026 · strength 0.61
- Paper Multi-modal spatial glycomic analysis of lymphoid aggregates in prostate and pancreatic cancer tissues. DOI 10.3389/fonc.2026.1935795↗
- Paper Combined Flt3L and CD40 agonism restores dendritic cell-driven T cell immunity in pancreatic cancer. DOI 10.1126/sciimmunol.adp3978↗
- Paper Senescence Defines a Distinct Subset of Myofibroblasts That Orchestrates Immunosuppression in Pancreatic Cancer. DOI 10.1158/2159-8290.cd-23-0428↗
- David G DeNardo · 3 shared papers, 2024–2026 · strength 0.61
- Paper Multi-modal spatial glycomic analysis of lymphoid aggregates in prostate and pancreatic cancer tissues. DOI 10.3389/fonc.2026.1935795↗
- Paper Combined Flt3L and CD40 agonism restores dendritic cell-driven T cell immunity in pancreatic cancer. DOI 10.1126/sciimmunol.adp3978↗
- Paper Senescence Defines a Distinct Subset of Myofibroblasts That Orchestrates Immunosuppression in Pancreatic Cancer. DOI 10.1158/2159-8290.cd-23-0428↗
- Varintra E. Lander · 2 shared papers, 2024–2025 · strength 0.36
- Ryan C Fields · 2 shared papers, 2024–2025 · strength 0.36
- Kameisha V. Rashford · 1 shared paper, 2026 · strength 0.24
- Colin T. McDowell · 1 shared paper, 2026 · strength 0.24
- Joseph E. Ippolito · 1 shared paper, 2026 · strength 0.24
- Richard R. Drake · 1 shared paper, 2026 · strength 0.24
- Graham D. Hogg · 1 shared paper, 2025 · strength 0.19
- William G. Hawkins · 1 shared paper, 2025 · strength 0.19
- Alyssa G. Weinstein · 1 shared paper, 2025 · strength 0.19
- Tiantian Liu · 1 shared paper, 2025 · strength 0.19
- Roheena Z. Panni · 1 shared paper, 2025 · strength 0.19
- John M. Baer · 1 shared paper, 2024 · strength 0.17
- Paolo Provenzano · 1 shared paper, 2024 · strength 0.17
- Jad I. Belle · 1 shared paper, 2024 · strength 0.17
- Guhan Qian · 1 shared paper, 2024 · strength 0.17
- Hyun Jee Kim · 1 shared paper, 2024 · strength 0.17
- Li Ding · 1 shared paper, 2024 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.